DDS vs. NVO
Compare and contrast key facts about Dillard's, Inc. (DDS) and Novo Nordisk A/S (NVO).
Performance
DDS vs. NVO - Performance Comparison
Loading graphics...
DDS vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
DDS Dillard's, Inc. | -4.81% | 46.81% | 13.47% | 32.05% | 38.66% | 306.41% | -12.71% | 22.76% | 0.97% | -3.63% |
NVO Novo Nordisk A/S | -25.80% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
Fundamentals
DDS:
$9.00B
NVO:
$162.26B
DDS:
$36.38
NVO:
$22.15
DDS:
15.86
NVO:
1.65
DDS:
1.40
NVO:
0.55
DDS:
3.83
NVO:
0.84
DDS:
$6.47B
NVO:
$297.20B
DDS:
-$644.80M
NVO:
$240.66B
DDS:
$878.26M
NVO:
$153.18B
Returns By Period
In the year-to-date period, DDS achieves a -4.81% return, which is significantly higher than NVO's -25.80% return. Over the past 10 years, DDS has outperformed NVO with an annualized return of 24.86%, while NVO has yielded a comparatively lower 5.04% annualized return.
DDS
- 1D
- 0.83%
- 1M
- -4.99%
- YTD
- -4.81%
- 6M
- -4.24%
- 1Y
- 66.79%
- 3Y*
- 30.02%
- 5Y*
- 51.68%
- 10Y*
- 24.86%
NVO
- 1D
- -0.73%
- 1M
- -0.01%
- YTD
- -25.80%
- 6M
- -36.19%
- 1Y
- -43.88%
- 3Y*
- -20.88%
- 5Y*
- 3.69%
- 10Y*
- 5.04%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DDS vs. NVO — Risk / Return Rank
DDS
NVO
DDS vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Dillard's, Inc. (DDS) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| DDS | NVO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.51 | -0.81 | +2.33 |
Sortino ratioReturn per unit of downside risk | 2.12 | -0.99 | +3.11 |
Omega ratioGain probability vs. loss probability | 1.28 | 0.86 | +0.42 |
Calmar ratioReturn relative to maximum drawdown | 3.23 | -0.82 | +4.05 |
Martin ratioReturn relative to average drawdown | 8.63 | -1.41 | +10.04 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| DDS | NVO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.51 | -0.81 | +2.33 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.98 | 0.10 | +0.88 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.42 | 0.16 | +0.26 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.23 | 0.46 | -0.23 |
Correlation
The correlation between DDS and NVO is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
DDS vs. NVO - Dividend Comparison
DDS's dividend yield for the trailing twelve months is around 5.40%, more than NVO's 4.94% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DDS Dillard's, Inc. | 5.40% | 5.13% | 6.02% | 5.18% | 4.89% | 6.41% | 0.95% | 0.68% | 0.66% | 0.57% | 0.45% | 0.40% |
NVO Novo Nordisk A/S | 4.94% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Drawdowns
DDS vs. NVO - Drawdown Comparison
The maximum DDS drawdown since its inception was -93.62%, which is greater than NVO's maximum drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for DDS and NVO.
Loading graphics...
Drawdown Indicators
| DDS | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.62% | -74.70% | -18.92% |
Max Drawdown (1Y)Largest decline over 1 year | -21.13% | -55.03% | +33.90% |
Max Drawdown (5Y)Largest decline over 5 years | -49.71% | -74.70% | +24.99% |
Max Drawdown (10Y)Largest decline over 10 years | -76.57% | -74.70% | -1.87% |
Current DrawdownCurrent decline from peak | -17.58% | -73.49% | +55.91% |
Average DrawdownAverage peak-to-trough decline | -35.72% | -17.56% | -18.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.92% | 31.83% | -23.91% |
Volatility
DDS vs. NVO - Volatility Comparison
Dillard's, Inc. (DDS) has a higher volatility of 10.84% compared to Novo Nordisk A/S (NVO) at 9.39%. This indicates that DDS's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| DDS | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.84% | 9.39% | +1.45% |
Volatility (6M)Calculated over the trailing 6-month period | 30.19% | 38.79% | -8.60% |
Volatility (1Y)Calculated over the trailing 1-year period | 44.33% | 54.16% | -9.83% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 52.94% | 37.82% | +15.12% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 59.60% | 32.28% | +27.32% |
Financials
DDS vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Dillard's, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities